SKK
GSK icon

Shepherd Kaplan Krochuk’s GSK GSK Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31,956
Closed -$1.31M – 52
2024
Q3 		$1.31M Buy
31,956
+76
+0.2% +$3.11K 0.99% 29
2024
Q2 		$1.23M Buy
31,880
+1
+0% +$42 0.97% 31
2024
Q1 		$1.37M Buy
31,879
+417
+1% +$17.2K 1.09% 27
2023
Q4 		$1.17M Sell
31,462
-2,407
-7% -$86.4K 0.95% 30
2023
Q3 		$1.23M Buy
+33,869
New +$1.2M 1.07% 26
2020
Q4 		– Sell
-17,520
Closed -$824K – 193
2020
Q3 		$824K Sell
17,520
-802
-4% -$40.2K 0.34% 49
2020
Q2 		$934K Buy
+18,322
New +$940K 0.42% 40

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Shepherd Kaplan Krochuk's GSK Position: Q4 2024 in Review

Shepherd Kaplan Krochuk sold out of GSK (GSK) in Q4 2024, closing a stake of 31,956 shares — an estimated $1.31M sold.

Shepherd Kaplan Krochuk first reported a position in GSK in Q2 2020 and held it in 7 quarters. The position peaked at $1.37M in Q1 2024. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Shepherd Kaplan Krochuk reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 31,956 GSK shares in Q4 2024, an estimated $1.31M.
  • Shepherd Kaplan Krochuk first reported a position in GSK in Q2 2020 and held it in 7 quarters.
  • Shepherd Kaplan Krochuk's GSK position peaked at $1.37M in Q1 2024.
  • 849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2024, filed 14 Feb 2025.